First-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation

dc.contributor.authorTeixidó Condomines, Elisabet
dc.contributor.authorRiera-Colomer, Clara
dc.contributor.authorRaldúa, Demetrio
dc.contributor.authorPubill Sánchez, David
dc.contributor.authorEscubedo Rafa, Elena
dc.contributor.authorBarenys Espadaler, Marta
dc.contributor.authorLópez Arnau, Raúl
dc.date.accessioned2026-01-12T07:56:08Z
dc.date.available2026-01-12T07:56:08Z
dc.date.issued2023-09-08
dc.date.updated2026-01-12T07:56:08Z
dc.description.abstractThe increasing number of new psychoactive substances (NPS) entering the illicit drug market, especially synthetic cathinones, as well as the risk of cardiovascular complications, is intensifying the need to quickly assess their cardiotoxic potential. The present study aims to evaluate the cardiovascular toxicity and lethality induced by first-generation synthetic cathinones (mephedrone, methylone, and MDPV) and more classical psychostimulants (cocaine and MDMA) in zebrafish embryos using a new approach methodology (NAM). Zebrafish embryos at 4 dpf were exposed to the test drugs for 24 h to identify drug lethality. Drug-induced effects on ventricular and atrial heart rate after 2 h exposure were evaluated, and video recordings were properly analyzed. All illicit drugs displayed similar 24 h LC<sub>50</sub> values. Our results indicate that all drugs are able to induce bradycardia, arrhythmia, and atrial-ventricular block (AV block), signs of QT interval prolongation. However, only MDPV induced a different rhythmicity change depending on the chamber and was the most potent bradycardia and AV block-inducing drug compared to the other tested compounds. In summary, our results strongly suggest that the NAM presented in this study can be used for screening NPS for their cardiotoxic effect and especially for their ability to prolong the QT intervals.
dc.format.extent1 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec740458
dc.identifier.issn1661-6596
dc.identifier.urihttps://hdl.handle.net/2445/225259
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms241813869
dc.relation.ispartofInternational Journal of Molecular Sciences, 2023, vol. 24, num.18
dc.relation.urihttps://doi.org/10.3390/ijms241813869
dc.rightscc-by (c) Teixidó, E. et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.classificationDrogues
dc.subject.classificationFarmacocinètica
dc.subject.classificationToxicologia
dc.subject.otherDrugs of abuse
dc.subject.otherPharmacokinetics
dc.subject.otherToxicology
dc.titleFirst-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
835341.pdf
Mida:
2.94 MB
Format:
Adobe Portable Document Format